Guggenheim Initiates Coverage On Repligen with Neutral Rating
Portfolio Pulse from Benzinga Newsdesk
Guggenheim has initiated coverage on Repligen (NASDAQ:RGEN) with a Neutral rating, as per analyst Subbu Nambi.
June 18, 2024 | 10:45 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Guggenheim has initiated coverage on Repligen with a Neutral rating, indicating a balanced view on the stock's potential performance.
The Neutral rating from Guggenheim suggests that the analyst does not see significant upside or downside potential in the short term for Repligen. This balanced view is likely to result in a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100